Improving Outcomes in Hypertensive Patients: Focus on Adherence and Persistence With Antihypertensive Therapy

被引:74
|
作者
Elliott, William J. [1 ]
机构
[1] Rush Univ, Dept Prevent Med, Rush Med Coll, Med Ctr, Chicago, IL 60612 USA
来源
JOURNAL OF CLINICAL HYPERTENSION | 2009年 / 11卷 / 07期
关键词
BLOOD-PRESSURE CONTROL; MEDICATION ADHERENCE; COMBINATION THERAPY; HEART-DISEASE; DISCONTINUATION; RISK; MONOTHERAPY; DETERMINANTS; TOLERABILITY; AMLODIPINE;
D O I
10.1111/j.1751-7176.2009.00138.x
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Although effective control of blood pressure ( BP) reduces the risk of cardiovascular events in patients with hypertension, BP control rates among treated patients in actual clinical practice are less than optimal. Although the costs of medicines and medical care (which are difficult to estimate both in clinical trials and general clinical practice) are important, medication-taking behavior-adherence and persistence with antihypertensive regimens-influences BP control rates. Many factors affect adherence and persistence with medications, including efficacy and tolerability of drugs prescribed, such that rates vary greatly among antihypertensive classes. In general, medications with fewer adverse effects (in registration trials or large outcomes studies) are associated with increased adherence and lower discontinuation rates. More widespread use of such agents, particularly those available in generic formulations or in low-cost formularies, may lead to better long-term BP control and fewer cardiovascular events. J Clin Hypertens (Greenwich). 2009; 11: 376-382. (C) 2009 Wiley Periodicals, Inc.
引用
收藏
页码:376 / 382
页数:7
相关论文
共 50 条
  • [31] Antihypertensive therapy for the prevention of nephropathy in diabetic hypertensive patients
    Isaacs, A. N.
    Vincent, A.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2016, 41 (02) : 111 - 115
  • [32] Renal protection in hypertensive patients: Selection of antihypertensive therapy
    Wenzel, RR
    DRUGS, 2005, 65 : 29 - 39
  • [33] Selection of antihypertensive therapy for patients with hypertensive renal disease
    Papademetriou, V
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (21): : 2774 - 2776
  • [34] Treatment adherence, clinical outcomes, and economics of triple-drug therapy in hypertensive patients
    Panjabi, Sumeet
    Lacey, Michael
    Bancroft, Timothy
    Cao, Felix
    JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION, 2013, 7 (01) : 46 - 60
  • [35] ADHERENCE TO THERAPY AND QUALITY OF LIFE IN HYPERTENSIVE PATIENTS
    Mollaoglu, Mukadder
    Solmaz, Gurcan
    Mollaoglu, Muratcan
    ACTA CLINICA CROATICA, 2015, 54 (04) : 438 - 444
  • [36] Patient adherence and persistence with antihypertensive therapy: One versus two-pill combinations
    Sturkenboom, MCJM
    Picelli, G
    Dieleman, JP
    Mozaffari, E
    Pompen, M
    van der Lei, J
    JOURNAL OF HYPERTENSION, 2005, 23 : S326 - S326
  • [37] Preliminary Analyses of Primary Adherence and Persistence to Antihypertensive Therapy in Portuguese Primary Care Units
    Coelho, Andre F.
    Caetano, Pedro A.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 : 495 - 495
  • [38] Differential persistence with initial antihypertensive therapies: a clue for understanding the needs of hypertensive patients
    Waeber, Bernard
    Burnier, Michel
    JOURNAL OF HYPERTENSION, 2006, 24 (06) : 1021 - 1022
  • [39] Assessment of adherence to antihypertensive therapy
    Varleta, Paola
    Akel, Carlos
    Acevedo, Monica
    Salinas, Claudia
    Pino, Javier
    Opazo, Viviana
    Garcia, Ana
    Echegoyen, Carolina
    Rodriguez, Daniel
    Gramusset, Lissette
    Leon, Sandra
    Cofre, Pedro
    Hernandez, Hilda
    Neira, Patricia
    Retamal, Raquel
    Petit, Gloria
    Moya, Natalia
    REVISTA MEDICA DE CHILE, 2015, 143 (05) : 569 - 576
  • [40] Cardiovascular outcomes of lifestyle intervention in hypertensive patients with antihypertensive agents
    Hua, Kun
    Hao, Guang
    Li, Wei
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2017, 227 : 751 - 756